✦ LIBER ✦

Quantification of endometriosis-associated pain and quality of life during the stimulatory phase of gonadotropin-releasing hormone agonist therapy: A double-blind, randomized, placebo-controlled trial

✍ Scribed by James D Miller

Book ID: 114486874
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 102 KB
Volume: 182
Category: Article
ISSN: 1097-6868
DOI: 10.1067/mob.2000.106846

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gonadotropin-releasing hormone agonist p

Gonadotropin-releasing hormone agonist plus “add-back” hormone replacement therapy for treatment of endometriosis: a prospective, randomized, placebo-controlled, double-blind trial

✍ Henk R Franke; Peter H.M van de Weijer; Ton M.M Pennings; Marius J van der Moore 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 94 KB

Gonadotropin-releasing hormone agonist p

Gonadotropin-releasing hormone agonist plus ‘add-back’ for the treatment of endometriosis. A prospective, randomized, placebo controlled, double blind trial

✍ H.R. Franke; P.H.M. van der Weijer; T.M.M. Pennings; M.J. van der Mooren 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 152 KB

(739/Paper 318): A randomized double-bli

(739/Paper 318): A randomized double-blind placebo controlled trial assessing the effect of the oral cannabinoid nabilone on pain and quality of life in patients with fibromyalgia

✍ R. Skrabek; L. Galimova 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Rilonacept (Interleukin-1 Trap) in the p

Rilonacept (Interleukin-1 Trap) in the prevention of acute gout flares during initiation of urate-lowering therapy: Results of a phase II randomized, double-blind, placebo-controlled trial

✍ H. Ralph Schumacher Jr.; John S. Sundy; Robert Terkeltaub; Howard R. Knapp; Scot 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB 👁 3 views

Impact of ustekinumab on health-related

Impact of ustekinumab on health-related quality of life in Japanese patients with moderate-to-severe plaque psoriasis: Results from a randomized, double-blind, placebo-controlled phase 2 / 3 trial

✍ Hidemi NAKAGAWA; Brad SCHENKEL; Mai KATO; Takeshi KATO; Atsuyuki IGARASHI; The J 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 French ⚖ 317 KB